[go: up one dir, main page]

MX2013008137A - Procedimientos para tratar la prostatitis. - Google Patents

Procedimientos para tratar la prostatitis.

Info

Publication number
MX2013008137A
MX2013008137A MX2013008137A MX2013008137A MX2013008137A MX 2013008137 A MX2013008137 A MX 2013008137A MX 2013008137 A MX2013008137 A MX 2013008137A MX 2013008137 A MX2013008137 A MX 2013008137A MX 2013008137 A MX2013008137 A MX 2013008137A
Authority
MX
Mexico
Prior art keywords
methods
treating prostatitis
prostatitis
silodosin
treating
Prior art date
Application number
MX2013008137A
Other languages
English (en)
Inventor
Kim Caramelli
Gary Hoel
Lawrence Hill
Original Assignee
Actavis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Inc filed Critical Actavis Inc
Publication of MX2013008137A publication Critical patent/MX2013008137A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se ha descubierto que la silodosina es eficaz en el tratamiento con silodosina o una sal farmacéutiamente aceptable de la misma a pacientes que tienen síntomas asociados con la prostatitis. En una realización preferida, se trata a los pacientes con 4 mg una vez al día.
MX2013008137A 2011-01-13 2012-01-09 Procedimientos para tratar la prostatitis. MX2013008137A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161432571P 2011-01-13 2011-01-13
US13/033,483 US20120184591A1 (en) 2011-01-13 2011-02-23 Methods for treating prostatitis
PCT/US2012/020692 WO2012096904A1 (en) 2011-01-13 2012-01-09 Methods for treating prostatitis

Publications (1)

Publication Number Publication Date
MX2013008137A true MX2013008137A (es) 2014-03-21

Family

ID=46491235

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008137A MX2013008137A (es) 2011-01-13 2012-01-09 Procedimientos para tratar la prostatitis.

Country Status (5)

Country Link
US (1) US20120184591A1 (es)
BR (1) BR112013017829A2 (es)
CA (1) CA2823655A1 (es)
MX (1) MX2013008137A (es)
WO (1) WO2012096904A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104211631A (zh) * 2013-05-30 2014-12-17 中国科学院上海药物研究所 一类吲哚类化合物、其制备方法、药物组合物及应用
KR102496504B1 (ko) 2018-03-23 2023-02-06 라보라뚜아르 마조르 남성 피임을 위한 비호르몬 조성물 및 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0600675B1 (en) 1992-12-02 1998-07-08 Kissei Pharmaceutical Co., Ltd. Indoline compounds for the treatment of dysuria
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤

Also Published As

Publication number Publication date
CA2823655A1 (en) 2012-07-19
BR112013017829A2 (pt) 2016-10-11
US20120184591A1 (en) 2012-07-19
WO2012096904A1 (en) 2012-07-19

Similar Documents

Publication Publication Date Title
AU2011328009A8 (en) Compounds and methods for treating pain
MY186977A (en) Tetrasubstituted alkene compounds and their use
MX363243B (es) Composiciones para tratar cáncer y usos de dichas composiciones.
BR112016018170A2 (pt) métodos para tratar doença de alzheimer
PH12015502091A1 (en) Cdc7 inhibitors
PH12013502487A1 (en) Sglt-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents
PH12014501844A1 (en) Peptidomimetic macrocycles
MX2014003180A (es) Metodos para tratar vhc.
WO2013056148A3 (en) Scd1 antagonists for treating cancer
MX350745B (es) El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
PH12012500916B1 (en) Treatments for gastrointestinal disorders
PH12016500270A1 (en) Combination of a mek inhibitor and an erk inhibitor for use in treatment of hyperproliferative diseases
PH12014500508A1 (en) Treating cough and tussive attacks
MX2011012131A (es) Perhexilina para usarla en el tratamiento de miocardiopatía hipertrófica (hcm).
MX367811B (es) D-metadona para el tratamiento de síntomas psiquiátricos.
EA201190337A1 (ru) Способ лечения
AR086422A1 (es) Metodo para el tratamiento de tumores solidos avanzados, volasertib
MX356704B (es) Combinación.
SG10201804034QA (en) Methods for treating hypotension
JO3145B1 (ar) مركبات مفيدة لتثبيط chk1
PH12014500381A1 (en) Therapeutic methods
MX2013008137A (es) Procedimientos para tratar la prostatitis.
EP3449917A3 (en) Tapentadol for preventing chronification of pain
TN2013000134A1 (en) Combination therapy for treating hcv infection
UA43018U (en) Method for immunocorrection of chronic polypous ethmoiditis

Legal Events

Date Code Title Description
FA Abandonment or withdrawal